Previous Close | 18.78 |
Open | 19.17 |
Bid | 7.99 x 800 |
Ask | 29.75 x 800 |
Day's Range | 18.44 - 20.29 |
52 Week Range | 17.56 - 32.00 |
Volume | |
Avg. Volume | 240,311 |
Market Cap | 786.46M |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.02 |
Earnings Date | Jul 11, 2022 - Jul 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 36.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for ANGO
LATHAM, N.Y., May 16, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference at 4:15 p.m. ET on Monday
LATHAM, N.Y., May 03, 2022--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Healthcare Conference at 10:00 a.m. PT (1:
The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...